Breakthrough — Radiopharmaceutical therapy represents a novel approach to treating cancer, utilising radioactive atoms to target and destroy malignant cells with precision, without affecting the patient’s healthy tissues.

In recognition of Breast Cancer Awareness Month, Ashley Hunter, Head of Strategic Development and Delivery…

One of the biggest challenges for researchers today is the threat of a conflict of interest in clinical trials (COI).

Clinical trials are designed to make sure that new treatments are better than existing ones. To do this, trials are structured by a framework that is made up of phases.

Decentralised clinical trials are a type of trial design used by studies to collect data from their participants. How data is collected can impact the trial’s efficiency, accuracy, and overall success and outcome.

Insights from Matilde Thye Kveiborg, Director of Medical Writing and Tanja Jensen, Senior Medical Writer

Rare diseases are often multifaceted, and a single endpoint is often not sufficient to fully describe treatment

At the bottom of the EBM hierarchy, mechanistic evidence is not highly valued by the HTA bodies responsible for…

Lionel RIOU FRANÇA, Chief Scientific Officer, was involved in two analyses involving patients with Late-Onset Pompe…

Cell and gene therapies are multiplying, and with them the hopes of patients, their families, and healthcare professionals…